Brucellosis in patients infected with the human immunodeficiency virus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 5, 1998, Pages 319-326

  Moreno, S ^a   Ariza, J ^b   Espinosa, F J ^a   Podzamczer, D ^b   Miro J M ^c   Rivero, A ^d   Rodriguez Zapata M ^e   Arrizabalaga, J ^f   Mateos, R ^g   Herrero, F ^a  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b L'Hospitalet de Lloibregat   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^f Hospital Nuestra Senora de Aranzazu   (Spain)

^g HOSPITAL RAFAEL MÉNDEZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; ANTIBIOTIC AGENT; ANTIBODY; CD4 ANTIGEN; DOXYCYCLINE; STREPTOMYCIN;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BACTERIUM CULTURE; BRUCELLOSIS; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MALE; MYALGIA; PRIORITY JOURNAL; RECURRENT DISEASE; SPAIN; SWEATING; SYMPTOM;

ADULT; BRUCELLOSIS; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; SPAIN; STREPTOMYCIN; TREATMENT OUTCOME;

EID: 7344252451     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050075     Document Type: Article

References (44)

1. Ariza J: Brucelosis, algunos aspectos de su epidemiologia. Enfermedades Infecciosas y Microbiologia Clínica (1989) 7:517-518
2. Buchanan TM, Hendricka S, Paton CH, Feldman RA: Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine (1974) 53:427-438
3. Lulu AR, Araj GF, Khateeh MI, Mustafa MY, Yusuf AR, Fenech FF: Human brucellosis in Kuwait: a prospective study of 400 cases. Quarterly Journal of Medicine (1988) 66:39-54
4. Mousa ARM, Elhag KM, Khogali M, Marafie AA: The nature of human brucellosis in Kuwait: study of 379 cases. Reviews of Infectious Diseases (1988) 10:211-217
5. Spink WW: The nature of brucellosis. University of Minnesota Press, Minneapolis, 1956, pp. 145-190
6. Wise RI: Brucellosis in the United Stales. Past, present and future. Journal of the American Medical Association (1980) 244:2318-2322
7. Young EJ: An overview of human brucellosis. Clinical Infectious Diseases (1995) 21:283-290
8. Oksenhendler E, Morinière B, Rouveix E: Brucellosis in hairy cell leukaemia. Transactions of the Royal Society of Tropical Medicine and Hygiene (1988) 82:336
9. Raziuddin S, Bilal N, Benjamin B: Transient T-cell abnormality in a selective IgM-immunodeficient patient with Brucella infection. Clinical Immunology and Immunopathology (1988) 46:360-367
10. Martín I, Ramos C, Gutiérrez A, Arazo P, Aguirre JM: Infección por VIH y brucelosis crónica. Enfermedades Infecciosas y Microbiologia Clínica (1992) 10:566-567
11. Pedro-Botet J, Coll J, Auguet T, Rubiés-Prat J: Brucellosis and HIV infection: a casual association? AIDS (1992) 6:1039-1040
12. Rubio A, Portu J. Zubizarreta J, Ayensa C: Meningitis por Brucella abortus en un paciente con infección por el virus de la immunodeficiencia humana. Medicina Clinica (Barcelona) (1992) 99:678
13. Valladares M, Viciana P, Martín A, del Nozal M: Brucelosis aguda e infección por VIH: una nueva particularidad. Enfermedades Infecciosas y Microbiologia Clínica (1993) 11:511-512
14. Ministerio de Sanidad y Consumo, Dirección General de Salud Pública: Comentario epidemiológico de las enfermedades de declaración obligatoria nacional. Año 1988. Boletin Epidemiológico Semanal (1989), No. 1825
15. Ministerio de Sanidad y Consumo: Epidemiologia del SIDA en España. DIN Impresores, Madrid, December (1995):7-90
16. Alton GG, Jones LM, Pietz DE: Laboratory techniques in brucellosis. World Health Organization Monograph No. 55 (1975), p. 11-67
17. Jones LM, Wundt W: International Committee on Nomenclature of Bacteria. Subcommittee on the Taxonomy of Brucella. Minutes of meeting. International Journal of Systematic Bacteriology (1971) 21:126-128
18. Morgan WP, Mackinnon DJ, Lawson JR, Cullen GA: The rose Bengal plate agglutination test in the diagnosis of brucellosis. Veterinaire Recherche (1969) 85:636-641
19. Ruiz-Castañeda M: Laboratory diagnosis of brucellosis in man. Bulletin of the World Health Organization (1961) 24:73-84
20. Colmenero JD, Reguera JM, Martos F, Sánchez de Mora D, Delgado M, Causse M: Complications associated with Brucella melitensis infection: Study of 530 cases. Medicine (1996) 75:195-211
21. Sulitzeanu D: Mechanisms of immunity against Brucella. Nature (1965) 205:1086-1088
22. Pantaleo G, Graziosi C, Fauci AS: New concepts in the immunopathogenesis of human immunodeficiency virus infection. New England Journal of Medicine (1993) 328:327-335
23. Grupo de Trabajo para el Estudio de Infecciones en Drogadictos: Estudio multicéntrico de las complicaciones infecciosas en adictos a drogas por vía parenteral en España: análisis final de 17.592 casos (1977-1991). Enfermedades Infecciosas y Microbiologia Clinica (1995) 13:532-539
24. Giasuddin ASM, Ziu MM, Shaafie IA: Brucella and HIV-1 antibodies in Libyan blood donors. Journal of Infection (1991) 22:294-296
25. Paul J, Gilks C, Batchelor B, Ojoo J, Amir M, Selkon JB: Serological response to brucellosis in HIV-seropositive patients. Transactions of the Royal Society of Tropical Medicine and Hygiene (1995) 89:228-230
26. Buchanan TM, Hendricka S, Paton CH, Feldman RA: Brucellosis in the United States, 1960-1972. An abbattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine (1974) 53:427-438
27. Ariza J, Pujol M, Valverde J, Nolla JM, Rufí G. Fernández-Viladrich P: Brucellar sacroiliitis: findings in 63 episodes and current relevance. Clinical Infectious Diseases (1993) 16:761-765
28. Mousa ARM, Muhtaseb SA, Almudallal DS., Khodeir SM. Marafie AA: Osteoarticular complication of brucellosis: a study of 169 cases. Reviews of Infectious Diseases (1987) 9:531-543
29. Galle C, Struelens M, Liesnard C, Godfraid J, Yaes N, Dewitte O, Farber CM, Clevenberg P, Van Vooren JP: Brucella melitensis osteitis following craniotomy in a patient with AIDS. Clinical Infectious Diseases 1997, 24: 1012
30. Acocella G, Bertrand A, Beytout J, Durrande JB, García-Rodríguez JA. Kosmidis J: Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. Journal of Antimicrobial Chemotherapy (1989) 23:433-439
31. Ariza J, Gudiol F, Pallarés R, Fernández-Viladrich P, Rufí G, Corredoira J: Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Annals of Internal Medicine (1992) 117:25-30
32. Ariza J, Gudiol F, Pallarés R, Rufí G, Fernández-Viladrich P: Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrobial Agents and Chemotherapy (1985) 28:548-551
33. Cisneros JM, Viciana P, Colmenero J, Pachón J, Martínez C. Alarcón A: Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks. Antimicrobial Agents and Chemotherapy (1990) 34:881-883
34. Colmenero JD, Hernández S, Reguera JM, Cabrera F, Rius F, Alonso A: Comparative trial of doxycycline plus streptomycin versus dosyeycline plus rifampin for the therapy of human brucellosis. Chemotherapy (1989) 35:146-152
35. Solera J, Medrano F, Rodríguez M, Geijo P, Paulino J: Ensayo terapéutico comparative y multicéntrico de rifampicina y doxiciclina trente a estreptomicina y doxiciclina en la brucelosis humana. Medicina Clinica (1991) 96:649-653
36. Solera J, Rodríguez Zapata M, Geijo P, Largo J, Paulino J, Saez L: Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrobial Agents and Chemotherapy (1995) 39:2061-2067
37. Food and Agriculture Organization-World Health Organization: FAO-WHO Expert Committee on Brucellosis (6th report). WHO Technical Report Series (1986) 740:56-57
38. Burgaleta C: Actividad funcional de las células fagocíticas en la brucelosis. In: Baquero F. Buzón L (eds): Proceedings of an international symposium on brucellosis. Garsi, Madrid (1985). p. 43-49
39. Gazapo E, González Lahoz J, Subiza JL, Baquero M, Figueredo MA, Gómez de la Concha E: Suhpohlaciones linfocitarias en la evolución de la brucelosis, Revista Clinica Española (1990) 186:369-373
40. Renoux M, Renoux G: Brucellosis immunodepression and levamisole. Lancet (1977) i: 372
41. Riglar C, Cheers CH: Macrophage activation during experimental murine brucellosis. Inhibition of in vitro lymphocyte proliferation by Brucella activated macrophages. Cell Immunology (1980) 49: 168-177
42. Rodríguez-Zapata M, Alvarez Mon M, Salmerón I, Prieto A, Manzano L, Salmerón OJ: Diminished T lymphocyte proliferative response to polyclonal mitogens in acute brucellosis patients. Infection (1996) 24: 115-119
43. Rodríguez Zapata M, Salmerón I, Manzano L, Salmerón OJ, Prieto A, Alvarez Mon M: Defective interferon gamma production by T lymphocytes from acute brucellosis patients. European Journal of Clinical Investigation (1996) 26:136-140
44. Salmerón I, Rodríguez Zapata M, Salmerón O, Manzano L, Vaquer S, Alvarez Mon M: Impaired activity of natural killer cells in patients with acute brucellosis. Clinical Infectious Diseases (1992) 15:764-770